Skip to content

Efficacy of freeze-dried platelet-rich plasma (FD-PRP) in bone engineering: Pilot study

Efficacy of freeze-dried platelet-rich plasma (FD-PRP) in bone engineering: Pilot study - FD-PRP for bone engineering

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027144
Enrollment
10
Registered
2017-04-26
Start date
2017-05-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alveolar bone atrophy

Interventions

Intervention period: 4weeks Intervention volume: maximum 90ml of peripheral blood for providing FD-PRP Number of times of Intervention: 1 time

Sponsors

Department of Regenerative Oral Surgely, Nagasaki University Graduate School of Biomediacal Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who are partially or fully edentulous, and are required to treat by dental implants for prosthetic rehabilitation. 2. Patients who have insufficient bone height and/or width to place the dental implant 3. Patients who received the oral health care and maintain the good condition of Plaque Control. 4. The age of the patients: 20- to 75-years old

Exclusion criteria

Exclusion criteria: 1. All patients are required to be nonsmokers. 2. Patients who have systemic disease, malignances, chronic infections, immune system abnormalities, septicemia, syphilis, HBV, HCV, HTLV-1, HIV, pregnancy, dementia. 3. Patients who have disorder of blood coagulation. 4. Patients who have hepatitis function disorders, metabolic bone disease or skeletal dysplasia. 5. Patients who needs the legal representative.

Design outcomes

Primary

MeasureTime frame
Safety (including the adverse events)

Countries

Japan

Contacts

Public ContactYoshinori Sumita

Faculty of Dentistry, Nagasaki University Basic and Translational Research Center for Hard Tissue Disease

y-sumita@nagasaki-u.ac.jp095-819-7706

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026